These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15628797)

  • 1. [Pharmacokinetic substantiation of ceftriaxone prophylaxis of hereditary syphilis].
    Aleksandrova Sg
    Antibiot Khimioter; 2004; 49(6):15-9. PubMed ID: 15628797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative antibacterial prophylaxis in bone surgery: sufficiently high tissue levels with ceftriaxone (rocephin) 24 hours after a single dose of 2 g.
    Rudert W; Hennecke H; Adam D
    J Chemother; 1989 Jul; 1(4 Suppl):1046-7. PubMed ID: 16312765
    [No Abstract]   [Full Text] [Related]  

  • 3. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.
    Zhou P; Gu Z; Xu J; Wang X; Liao K
    Sex Transm Dis; 2005 Aug; 32(8):495-8. PubMed ID: 16041252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women.
    Popović J; Grujić Z; Sabo A
    J Clin Pharm Ther; 2007 Dec; 32(6):595-602. PubMed ID: 18021337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone (1 g intravenously) penetration into abdominal tissues when administered as antibiotic prophylaxis during nephrectomy.
    Leone M; Albanèse J; Tod M; Savelli V; Ragni E; Rossi D; Martin C
    J Chemother; 2003 Apr; 15(2):139-42. PubMed ID: 12797390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin versus penicillin for early syphilis.
    Ballard RC; Berman SM; Fenton KA
    N Engl J Med; 2006 Jan; 354(2):203-5; author reply 203-5. PubMed ID: 16407519
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of the congenital syphilis prevention programs].
    Daoud M; Duca E; Onofriescu M; Petrescu Z
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):934-7. PubMed ID: 22046811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
    Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
    Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Syphilis and pregnancy].
    Degos R
    Rev Fr Gynecol Obstet; 1971 Oct; 66(10):551-5. PubMed ID: 5144406
    [No Abstract]   [Full Text] [Related]  

  • 10. Missed opportunities for preventing congenital syphilis infection.
    Introcaso CE; Bradley H; Gruber D; Markowitz LE
    Sex Transm Dis; 2013 May; 40(5):431. PubMed ID: 23584807
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation.
    Iida S; Kawanishi T; Hayashi M
    J Pharm Pharmacol; 2011 Jan; 63(1):65-72. PubMed ID: 21155817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of congenital syphilis after maternal treatment with azithromycin during pregnancy.
    Zhou P; Qian Y; Xu J; Gu Z; Liao K
    Sex Transm Dis; 2007 Jul; 34(7):472-4. PubMed ID: 17589329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital syphilis: a case report].
    Lasfargue M; Thümmler S; Perelman S; de Ricaud D
    Arch Pediatr; 2009 Oct; 16 Suppl 2():S123-6. PubMed ID: 19836674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.
    Iida S; Kinoshita H; Kawanishi T; Hayashi M
    Eur J Drug Metab Pharmacokinet; 2009; 34(2):107-15. PubMed ID: 19645220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative antibiotic prophylaxis in transperitoneal tumor nephrectomy: does it lower the rate of clinically significant postoperative infections?].
    Steiner T; Traue C; Schubert J
    Urologe A; 2003 Jan; 42(1):34-7. PubMed ID: 12574881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling.
    Blumer JL; Reed MD; Kaplan EL; Drusano GL
    Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotics in therapy of syphilis in pregnancy and in prevention of congenital syphilis].
    SIBILLA A
    Riv Ostet Ginecol; 1957 Jan; 12(1):27-41. PubMed ID: 13454585
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of ceftriaxone in the tissues of the female genital system.
    Fraschini F; Zoncada F; Scaglione F; Radaelli U; Miraglia M; Valmaggi P; Falchi M; Ripamonti L
    Int J Clin Pharmacol Res; 1987; 7(6):499-502. PubMed ID: 3440640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ceftriaxone: whether there is future for it?].
    Sidorenko SV
    Antibiot Khimioter; 2006; 51(8):3-9. PubMed ID: 18030778
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentrations of ceftriaxone in plasma and in pus in patients with soft tissue abscesses.
    Georgopoulos A; Lang F; Hölbing N; Graninger W; Breyer S; Mailer H; Probst P
    J Chemother; 1989 Jul; 1(4 Suppl):522-3. PubMed ID: 16312513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.